breast cancer treatment

To kick off our new interview series Making the Rounds, we invited surgical oncologist Dr. Ogori Kalu to our New York office for a Facebook Live video streaming session to help educate the public on breast cancer prevention. Take a few minutes to learn about the discredited myths, and to watch the interesting round-table discussion with this Stanford-educated doctor.
Perhaps the most debilitating part of breast cancer treatment is chemotherapy. A new report by an international team of researchers suggests a means of more precisely determining which patients do or do not require chemotherapy.
Recent research has made some progress in finding an effective treatment for triple negative breast cancer — specifically, cancers that don't have either growth factor or hormone receptors. These are the most difficult to treat successfully, since there are no targeted therapies for them.
A study published online in Annals of Surgical Oncology reports that a week-long course of accelerated partial breast irradiation (APBI) after lumpectomy reduced rates of breast cancer recurrence and led to a 10-year survival rate of 96 percent. APBI is a localized form of radiation treatment meant to eliminate breast cancer cells that may remain after lumpectomy surgery.
Ductal carcinoma in situ (DCIS) is the presence of abnormal cells inside a milk duct in the breast. DCIS is considered the earliest form of breast cancer, and is the most common type of non-invasive breast cancer. DCIS